Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06524778
PHASE2

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital

View on ClinicalTrials.gov

Summary

This study is a prospective, single-arm, phase II, single-center study. Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and all patients receive a single dose of 10Gy of implantable brachytherapy. Record treatment-related acute events during and after treatment. Follow up on survival and local control after treatment ends, marking the end of the trial treatment.

Official title: The Therapeutic Effect of Single High-dose Brachytherapy for Locally Inoperable and Metastatic Giant Osteosarcoma Masses

Key Details

Gender

All

Age Range

12 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2024-08-30

Completion Date

2027-06-30

Last Updated

2024-08-07

Healthy Volunteers

No

Conditions

Interventions

RADIATION

brachytherapy

Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and all patients receive a single dose of 10Gy of implantable brachytherapy. Record treatment-related acute events during and after treatment. Follow up on survival and local control after treatment ends, marking the end of the trial treatment.